| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.07B | 18.01B | 22.20B | 19.86B | 17.73B | 13.41B |
| Gross Profit | 2.03B | 2.40B | 2.40B | 2.60B | 2.04B | 1.82B |
| EBITDA | 633.78M | 785.73M | 856.65M | 882.88M | 770.47M | 707.32M |
| Net Income | -73.31M | 206.49M | 334.02M | 326.25M | 312.37M | 292.62M |
Balance Sheet | ||||||
| Total Assets | 8.23B | 9.26B | 9.84B | 9.48B | 9.56B | 8.03B |
| Cash, Cash Equivalents and Short-Term Investments | 1.33B | 1.09B | 1.42B | 1.11B | 1.39B | 1.79B |
| Total Debt | 2.22B | 2.28B | 2.60B | 2.31B | 2.34B | 2.09B |
| Total Liabilities | 5.52B | 6.09B | 6.78B | 6.30B | 6.59B | 5.33B |
| Stockholders Equity | 2.61B | 3.07B | 2.98B | 3.09B | 2.91B | 2.65B |
Cash Flow | ||||||
| Free Cash Flow | 413.75M | 367.73M | 427.46M | 491.67M | 257.42M | 564.89M |
| Operating Cash Flow | 628.26M | 582.03M | 656.90M | 722.02M | 451.77M | 727.77M |
| Investing Cash Flow | 603.76M | -338.14M | -531.52M | -525.29M | -867.43M | -391.52M |
| Financing Cash Flow | -476.82M | -180.89M | -100.16M | -472.75M | 21.49M | -256.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £4.25B | -62.38 | 3.85% | 4.45% | -17.89% | -122.62% | |
71 Outperform | £1.52B | 9.42 | 12.03% | 5.83% | 159.13% | 143.76% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | £63.72M | 10.25 | 7.18% | 6.54% | -5.00% | -32.05% | |
63 Neutral | £813.10M | -5.06 | -22.53% | 10.54% | 56.20% | -185.69% | |
63 Neutral | £3.42B | -8.98 | -11.32% | 8.55% | 123.03% | -330.89% | |
45 Neutral | £160.87M | -0.11 | -123.27% | ― | -14.33% | -69.80% |
DCC plc has announced its total number of Ordinary Shares with voting rights, which stands at 97,028,512 as of 28 November 2025. The total issued share capital is 99,214,644 Ordinary Shares, with 2,186,132 held as Treasury Shares, which do not carry voting rights. This information is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules.
DCC plc has announced a proposed return of up to £600 million to its shareholders through a tender offer following the sale of DCC Healthcare. This initiative, subject to shareholder approval, will involve acquiring up to 12.3% of its current issued share capital at a premium price range. The tender offer, which opens today and closes on December 17, 2025, aims to provide shareholders with liquidity and optionality while potentially enhancing earnings per share by reducing the number of shares in issue. The tender offer will not affect shareholders’ entitlement to the interim dividend announced earlier in November.
DCC plc announced the grant of options under its Long Term Incentive Plan 2021 to key executives, including the CEO, COO, and CFO. These transactions, involving ordinary shares at €0.25 each, reflect the company’s ongoing strategy to align management incentives with performance metrics such as Group ROCE, EPS, and TSR over a three-year period, potentially impacting stakeholder interests and reinforcing DCC’s commitment to performance-driven growth.
DCC plc has made significant strategic progress by completing the sale of its Healthcare and Info Tech businesses, returning £100 million to shareholders, and planning a £600 million tender offer. Despite a 5.4% decline in continuing adjusted operating profit due to strong prior year comparatives and mild weather, the company saw improved trading in the second quarter and expects good profit growth for the full year. DCC’s focus on expanding its liquid gas activities in Europe and simplifying operations is expected to strengthen its market position and provide growth opportunities.
DCC plc has completed the sale of its Info Tech business in the UK and Ireland to AURELIUS, marking a significant step in its strategy to simplify operations and focus on its energy business, which is the largest and most profitable division. This move is expected to maximize shareholder value and accelerate growth in the energy sector, aligning with the company’s long-term strategic goals.
DCC plc has announced the acquisition of FLAGA GmbH, a leading distributor of liquid gas in Austria, and the AvantiGas liquid gas cylinder business in the UK, both from UGI International, LLC. These acquisitions are part of DCC’s strategy to expand its liquid gas business in new and existing geographies, marking its entry into the Austrian market and strengthening its position in the UK. The acquisition of FLAGA, valued at approximately €55 million, is expected to generate a mid-teen return on capital employed in the first year. These strategic moves align with DCC’s growth priorities in providing lower-carbon energy solutions and enhancing its leadership in the energy solutions market.
DCC plc, a prominent company, has announced the appointment of Ms. Caroline Dowling as a non-executive director of Fabrinet, effective from October 13, 2025. This move is in accordance with the Financial Conduct Authority’s Listing Rule 6.4.9. The appointment of Ms. Dowling to Fabrinet, a company listed on the New York Stock Exchange, could potentially enhance DCC plc’s strategic positioning and influence in the industry.
DCC plc, a company listed on the London Stock Exchange, has completed its share buyback program, which was initiated to repurchase ordinary shares worth up to £100 million. The company purchased 26,204 shares at a volume-weighted average price of 4733.46p, with the highest price paid per share being 4800p and the lowest 4674p. Following the settlement and cancellation of these shares, DCC will have 96,896,329 ordinary shares in issue. This move is part of DCC’s strategic financial management, potentially impacting shareholder value and market perception.
DCC plc, a company listed on the London Stock Exchange, has announced the purchase of 45,687 of its ordinary shares as part of its ongoing share buyback program. The shares were acquired at prices ranging from 4640p to 4960p, with an average price of 4796.87p, and will be cancelled, reducing the total number of shares in issue to 96,922,533. This buyback is part of a larger initiative to repurchase shares worth up to £100 million by the end of September 2025, which could potentially enhance shareholder value and improve the company’s financial metrics.
DCC plc has completed the sale of its healthcare division, marking a significant step in its strategy to simplify operations and focus on its energy business, which is its largest and most profitable division. The company plans to return £800 million from the sale to shareholders, with a £100 million share buyback already underway and a £600 million tender offer expected to be completed by December. This move aligns with DCC’s focus on delivering sustainable, long-term value for shareholders and stakeholders.
DCC plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 44,885 of its ordinary shares at a volume-weighted average price of 4718.00p per share. This transaction is part of a broader initiative to repurchase shares worth up to £100 million by the end of September 2025, which is expected to enhance shareholder value by reducing the number of shares in circulation.
DCC plc, a company listed on the London Stock Exchange, has announced the repurchase of 43,671 of its ordinary shares as part of a share buyback program. This buyback initiative, which aims to repurchase shares worth up to £100 million by the end of September 2025, is part of DCC’s strategy to enhance shareholder value and optimize its capital structure. The cancellation of these shares will reduce the total number of shares in issue, potentially increasing the value of remaining shares and reflecting positively on the company’s financial health.
DCC plc, a company listed on the London Stock Exchange, has executed a share buyback transaction as part of its ongoing Buyback Programme. On September 5, 2025, DCC purchased 43,366 of its ordinary shares, which will be subsequently canceled, at prices ranging between 4730p and 4800p per share. This transaction is part of a larger initiative to repurchase shares up to a total value of £100 million by the end of September 2025. The buyback is expected to reduce the number of shares in circulation, potentially increasing the value of remaining shares and reflecting the company’s confidence in its financial health.